Specific down-regulation of an engineered human cyclin D1 promoter by a novel DNA-binding ligand in intact cells

Nucleic Acids Research

Volumn 29, Issue 3, 2001, Pages 652-661

  Laurance, Megan E ^a,b   Starr, D Barry ^a   Michelotti, Emil F ^a   Cheung, Elaine ^a   Gonzalez, Carolyn ^a   Tam, Albert W ^a   Deikman, Jon ^a   Edwards, Cynthia A ^a,c   Bardwell, A Jane ^a,d  

^a Genelabs Incorporated   (United States)

^b Ingenuity Systems Inc   (United States)

^c Genecor International   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; LIGAND;

ARTICLE; BINDING SITE; BREAST CARCINOGENESIS; CANCER; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; DNA DETERMINATION; DNA FOOTPRINTING; DOWN REGULATION; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IN VIVO STUDY; MOLECULE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 0035253406     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/29.3.652     Document Type: Article

References (41)

1. Positive and negative regulation of endogenous genes by designed transcription factors
2. Zinc finger proteins as designer transcription factors
3. Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands
4. Inhibition of Ets-1 DNA binding and ternary complex formation between Ets-1, NF-kappaB and DNA by a designed DNA-binding ligand
5. Genetic alterations of cyclins, cyclin-dependent kinases and Cdk inhibitors in human cancer
6. Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients
7. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis
8. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells
9. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells
10. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum
11. Control of cyclin D1 expression by antisense oligonucleotides in three ovarian cancer cell lines
12. Inhibition of cell proliferation in head and neck squamous cell carcinoma cell lines with antisense cyclin D1
13. Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes
14. Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas
15. Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model
16. PRAD1/cyclin D1 proto-oncogene: Genomic organization, 5′ DNA sequence and sequence of a tumor-specific rearrangement breakpoint
17. Inducible regulatory elements in the human cyclin D1 promoter
18. Repression of cyclin D1: A novel function of MYC
19. Induction of cyclin D1 by simian virus 40 small tumor antigen
20. NF-kappaB function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S-phase transition
21. Transcriptional regulation of the cyclin D1 promoter by STAT5: Its involvement in cytokine-dependent growth of hematopoietic cells
22. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway
23. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
24. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions
25. Angiotensin II activation of cyclin D1-dependent kinase activity
26. Transforming growth factor-alpha enhances cyclin D1 transcription through the binding of early growth response protein to a cis-regulatory element in the cyclin D1 promoter
27. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Spl
28. Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes
29. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38 and Jun kinase pathways. A role for cAMP response element-binding protein and activating factor-2 in pp60(v-src) signaling in breast cancer cells
30. Footprinting with UV irradiation and LMPCR
31. Expression and amplification of cyclin genes in human breast cancer
32. New core promoter element in RNA polymerase II-dependent transcription: Sequence-specific DNA binding by transcription factor IIB
33. Cyclic adenosine 3′,5′-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins
34. Mammalian G1 cyclins
35. Nuclear protein CBP is a coactivator for the transcription factor CREB
36. Lessons from hereditary colorectal cancer
37. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
38. Beta-catenin mutations in cell lines established from human colorectal cancers
39. DNA sequence preferences of several AT-selective minor groove binding ligands
40. Crystal structure of a bZIP/DNA complex at 2.2 Å: Determinants of DNA specific recognition
41. Inhibition of major-groove-binding proteins by pyrrole-imidazole polyamides with an Arg-Pro-Arg positive patch